Patents by Inventor Jens Martin Heile

Jens Martin Heile has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ELICITING HCV-SPECIFIC ANTIBODIES
    Publication number: 20110159039
    Abstract: Described herein is a method of eliciting antibodies and neutralizing of binding antibodies against a hepatitis C virus (HCV) E1E2 or E2 antigen using HCV E2 or HCV E1E2 polypeptides and/or HCV E2 or E1E2 polynucleotides. Elicitation of anti-E2 antibodies and anti-E2 NOB antibodies can be used, inter alia, to provide model systems to optimize anti-E2 antibody responses and/or anti-E2 NOB antibody responses to HCV and to provide prophylactic or therapeutic treatment against HCV infection.
    Type: Application
    Filed: August 30, 2010
    Publication date: June 30, 2011
    Inventors: Michael Houghton, Mark Selby, Sergio Abrignani, Jens Martin Heile, Derek O'Hagan
  • Method for the concentration and purification of biological compounds
    Patent number: 7833796
    Abstract: The invention concerns materials and methods used for the concentration, desalination, purification or stabilization of biological compounds, in particular biological macromolecules and supramolecular structures, by means of superabsorbent polymers or superabsorptive composite materials.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: November 16, 2010
    Assignee: Preentec AG
    Inventors: Rene Pellaux, Jens-Martin Heile, Andreas Josef Schenzle, Martin Held
  • Eliciting HCV-specific antibodies
    Publication number: 20080095800
    Abstract: Described herein is a method of eliciting antibodies and neutralizing of binding antibodies against a hepatitis C virus (HCV) E1E2 or E2 antigen using HCV E2 or HCV E1E2 polypeptides and/or HCV E2 or E1E2 polynucleotides. Elicitation of anti-E2 antibodies and anti-E2 NOB antibodies can be used, inter alia, to provide model systems to optimize anti-E2 antibody responses and/or anti-E2 NOB antibody responses to HCV and to provide prophylactic or therapeutic treatment against HCV infection.
    Type: Application
    Filed: December 13, 2007
    Publication date: April 24, 2008
    Inventors: Michael Houghton, Mark Selby, Sergio Abrignani, Jens Martin Heile, Derek O'Hagan
  • Eliciting HCV-specific antibodies
    Patent number: 7329408
    Abstract: Described herein is a method of eliciting antibodies and neutralizing of binding antibodies against a hepatitis C virus (HCV) E1E2 or E2 antigen using HCV E2 or HCV E1E2 polypeptides and/or HCV E2 or E1E2 polynucleotides. Elicitation of anti-E2 antibodies and anti-E2 NOB antibodies can be used, inter alia, to provide model systems to optimize anti-E2 antibody responses and/or anti-E2 NOB antibody responses to HCV and to provide prophylactic or therapeutic treatment against HCV infection.
    Type: Grant
    Filed: December 1, 2000
    Date of Patent: February 12, 2008
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Michael Houghton, Mark Selby, Sergio Abrignani, Jens Martin Heile, Derek O'Hagan
  • Method for the concentration and purification of biological compounds
    Publication number: 20070111194
    Abstract: The invention concerns materials and methods used for the concentration, desalination, purification or stabilization of biological compounds, in particular biological macromolecules and supramolecular structures, by means of superabsorbent polymers or superabsorptive composite materials.
    Type: Application
    Filed: December 15, 2004
    Publication date: May 17, 2007
    Applicant: PREENTEC AG
    Inventors: Rene Pellaux, Jens-Martin Heile, Andreas Schenzle, Martin Held
  • Sorptive composite materials
    Publication number: 20050013788
    Abstract: The invention relates to sorptive composite materials comprising a sorbent entrapped in a cross-linked acrylic polymer. These composites can be tailored for extraction and feeding of compounds from/to liquid phases or multiphase systems such as cell suspensions. Key features of the sorptive composite materials arc stability (chemical, mechanical, biological and thermal), selectivity (physical and chemical), biocompatibility, and a characteristic upon which the sorptive composite materials can be separated from liquid or multi-phase systems. The invention also relates to techniques for the preparation of such sorptive composite materials as well as applications thereof.
    Type: Application
    Filed: October 28, 2002
    Publication date: January 20, 2005
    Inventors: Martin Held, Rene Pellaux, Jens-Martin Heile, Andreas Schenzle
  • Eliciting HCV-specific antibodies
    Publication number: 20020002272
    Abstract: Described herein is a method of eliciting antibodies and neutralizing of binding antibodies against a hepatitis C virus (HCV) E1E2 or E2 antigen using HCV E2 or HCV E1E2 polypeptides and/or HCV E2 or E1E2 polynucleotides. Elicitation of anti-E2 antibodies and anti-E2 NOB antibodies can be used, inter alia, to provide model systems to optimize anti-E2 antibody responses and/or anti-E2 NOB antibody responses to HCV and to provide prophylactic or therapeutic treatment against HCV infection.
    Type: Application
    Filed: December 1, 2000
    Publication date: January 3, 2002
    Inventors: Michael Houghton, Mark Selby, Sergio Abrignani, Jens Martin Heile, Derek O'Hagan